Insights
More with analytics
Cannabis-Infused Drinks: Exploring the New Beverage Trend
As the global soft-drink and alcohol consumption slows down, a growing number of companies think of cannabis beverages as a new growth vector. However, marketing cannabis-infused products could bring some reputational risks. An effective PR campaign can’t afford to...
Financial Crisis Anniversary: The Media’s Verdicts
Communication professionals working in finance could draw important lessons from the recent coverage of the financial crisis’ 10th anniversary – it encapsulates the PR problems that have been plaguing the industry for the last decade. Employing our media analytics...
Pharma and Mental Health: Reputation Challenges
Analysing the mental health coverage, we concluded that while the awareness of mental health issues is increasing, pharma’s reputation in this area lags behind: the number of mental health-related articles which mention pharma companies is very limited. In addition,...
Alzheimer’s in the Media: The Power of Influencers
Due to the 99.6% failure rate of new Alzheimer’s drugs, scepticism is the default attitude in the media coverage of everything around the increasingly occurring disease. To tackle the inevitable reputation hurdles, communication professionals should take advantage...
The Future of Pharma? Mapping the Gene Therapy Trend
In their latest study on the pharma market, intelligence provider Evaluate pointed out that the development and commercialisation of gene and cell therapies are turning into a powerful engine of value creation for pharma companies. The launch of these novel therapies...
Pharma start-ups in the media: communicating the industry’s future
A recent research conducted by PwC and CB Insights found that venture capitalists invested $10.6 billion into healthcare start-ups in the first half of 2018, with $5.3 billion spent in 216 healthcare deals in the second quarter of the year – a 21% increase from the...
Big Pharma vs Big Tech: Healthcare Innovation Trends in the Media
“Part of our competitors are not only the Novartis of the world and the other pharmas, but really the Amazons and Googles,” Yitzhak Peterburg, the former CEO of pharmaceutical giant Teva, said a year ago, adding that the global healthcare sector is facing a “huge...
US-China Trade War 2: Thought Leaders on the Battleground
As with the Brexit quandary, the economic turbulence surrounding the US-China trade skirmish presents an opportunity for many corporates to boost their brand presence in the media by establishing themselves as thought leaders. When reporting on the trade tensions...
US-China Trade War: Corporate Communications in the Battlefields
As the two largest national economies embroil in a trade showdown, it is individual companies which are in the centre of extensive reportages and economic commentary: the dispute is not just between the two countries, but also between corporations and policy makers,...
